Disc Medicine, Inc. Interest Income, Other
Disc Medicine, Inc. (IRON) reported Interest Income, Other of $6.53 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2026-07-30
- Disc Medicine, Inc. interest income, other for the quarter ending 2026-06-30 was $6.53M, a 7.44% decline year-over-year.
- Disc Medicine, Inc. interest income, other for the quarter ending 2026-03-31 was $6.89M, a 0.19% increase year-over-year.
- Disc Medicine, Inc. interest income, other for the quarter ending 2025-12-31 was $7.41M, a 26.96% increase year-over-year.
- Disc Medicine, Inc. interest income, other for the quarter ending 2025-09-30 was $6.41M, a 0.79% increase year-over-year.
- Disc Medicine, Inc. interest income, other for fiscal 2025 was $27.76M, a 30.38% increase from fiscal 2024.
- Disc Medicine, Inc. interest income, other for fiscal 2024 was $21.29M, a 43.89% increase from fiscal 2023.
- Disc Medicine, Inc. interest income, other for fiscal 2023 was $14.80M, a 1987.02% increase from fiscal 2022.
- Disc Medicine, Inc. interest income, other for fiscal 2022 was $709.00K, a 4964.29% increase from fiscal 2021.
| Period end | Interest Income, Other 3 month | Interest Income, Other 3 month as first filed | Interest Income, Other 6 month | Interest Income, Other 6 month as first filed | Interest Income, Other 9 month | Interest Income, Other 9 month as first filed | Interest Income, Other 12 month | Interest Income, Other 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.53M 10-Q · filed 2026-07-30 | $13.43M 10-Q · filed 2026-07-30 | $20.84M derived: sum of 3 quarters · filed 2026-07-30 | $27.25M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $6.89M 10-Q · filed 2026-05-05 | $14.30M derived: sum of 2 quarters · filed 2026-05-05 | $20.72M derived: sum of 3 quarters · filed 2026-05-05 | $27.77M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $7.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $13.82M derived: sum of 2 quarters · filed 2026-02-26 | $20.88M derived: sum of 3 quarters · filed 2026-07-30 | $27.76M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $6.41M 10-Q · filed 2025-11-06 | $13.47M derived: sum of 2 quarters · filed 2026-07-30 | $20.35M 10-Q · filed 2025-11-06 | $26.19M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $7.06M 10-Q · filed 2026-07-30 | $13.94M 10-Q · filed 2026-07-30 | $19.77M derived: sum of 3 quarters · filed 2026-07-30 | $26.14M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $6.88M 10-Q · filed 2026-05-05 | $12.72M derived: sum of 2 quarters · filed 2026-05-05 | $19.08M derived: sum of 3 quarters · filed 2026-05-05 | $23.65M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $5.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $12.20M derived: sum of 2 quarters · filed 2026-02-26 | $16.77M derived: sum of 3 quarters · filed 2026-02-26 | $21.29M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $6.36M 10-Q · filed 2025-11-06 | $10.94M derived: sum of 2 quarters · filed 2025-11-06 | $15.45M 10-Q · filed 2025-11-06 | $20.13M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $4.57M 10-Q · filed 2025-08-07 | $9.09M 10-Q · filed 2025-08-07 | $13.77M derived: sum of 3 quarters · filed 2026-02-26 | $18.61M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $4.52M 10-Q · filed 2025-05-07 | $9.20M derived: sum of 2 quarters · filed 2026-02-26 | $14.04M derived: sum of 3 quarters · filed 2026-02-26 | $16.95M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $4.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.52M derived: sum of 2 quarters · filed 2026-02-26 | $12.43M derived: sum of 3 quarters · filed 2026-02-26 | $14.80M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $4.84M 10-Q · filed 2024-11-12 | $7.75M derived: sum of 2 quarters · filed 2024-11-12 | $10.12M 10-Q · filed 2024-11-12 | $10.51M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $2.91M 10-Q · filed 2024-08-08 | $5.28M 10-Q · filed 2024-08-08 | $5.67M derived: sum of 3 quarters · filed 2024-08-08 | $5.93M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $2.37M 10-Q · filed 2024-05-09 | $2.75M derived: sum of 2 quarters · filed 2024-05-09 | $3.02M derived: sum of 3 quarters · filed 2024-05-09 | $3.07M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $388.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $657.00K derived: sum of 2 quarters · filed 2024-03-21 | $702.00K derived: sum of 3 quarters · filed 2024-03-21 | $709.00K 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | $269.00K 10-Q · filed 2023-11-09 | $499.00K 10-Q · filed 2022-11-10 | $314.00K derived: sum of 2 quarters · filed 2023-11-09 | $321.00K 10-Q · filed 2023-11-09 | $657.00K 10-Q · filed 2022-11-10 | $324.00K derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $45.00K 10-Q · filed 2023-08-11 | $149.00K 10-Q · filed 2022-08-11 | $52.00K 10-Q · filed 2023-08-11 | $158.00K 10-Q · filed 2022-08-11 | $55.00K derived: sum of 3 quarters · filed 2023-08-11 | $60.00K derived: sum of 4 quarters · filed 2023-08-11 | ||
| 2022-03-31 | $7.00K 10-Q · filed 2023-05-15 | $9.00K 10-Q · filed 2022-05-06 | $10.00K derived: sum of 2 quarters · filed 2023-05-15 | $15.00K derived: sum of 3 quarters · filed 2023-05-15 | $20.00K derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $8.00K derived: sum of 2 quarters · filed 2023-03-31 | $13.00K derived: sum of 3 quarters · filed 2023-03-31 | $14.00K 10-K · filed 2023-03-31 | $15.00K 10-K · filed 2022-03-10 | |||
| 2021-09-30 | $5.00K 10-Q · filed 2022-11-10 | $10.00K derived: sum of 2 quarters · filed 2022-11-10 | $11.00K 10-Q · filed 2022-11-10 | $14.04K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $5.00K 10-Q · filed 2022-08-11 | $6.00K 10-Q · filed 2022-08-11 | $9.04K derived: sum of 3 quarters · filed 2022-08-11 | $10.53K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $1.00K 10-Q · filed 2022-05-06 | $4.04K derived: sum of 2 quarters · filed 2022-05-06 | $5.53K derived: sum of 3 quarters · filed 2022-05-06 | |||||
| 2020-12-31 | $3.04K derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-29 | $4.53K 10-K · filed 2021-03-29 | $37.00K 10-K · filed 2022-03-10 | |||||
| 2020-09-30 | $1.49K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |